Comparing [18F]FDG PET/CT response criteria in melanoma and lung cancer patients treated with immunotherapy: a systematic review

[1] Ribas A(2018)Cancer immunotherapy using checkpoint blockade Science. 359 1350-1355

[2] Wolchok JD(2017)iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics Lancet Oncol England 18 e143-e152

[3] Seymour L(2018)Absolute number of new lesions on18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab Eur J Nucl Med Mol Imaging. 45 376-83

[4] Bogaerts J(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 332-336

[5] Perrone A(2011)QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 155 529-61

[6] Ford R(2021)Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments Res Synth Method. 121 55-286

[7] Schwartz LH(2013)Assessing Bias in Studies of Prognostic Factors Annals of Internal Medicine 158 280-16

[8] Mandrekar S(2007)Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 1-22

[9] Anwar H(2020)Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: an observational study PLoS Med 17 1-341

[10] Sachpekidis C(2020)Review manager (RevMan) [computer program] Version 5 4-1782

[1] Ribas A(2018)Cancer immunotherapy using checkpoint blockade Science. 359 1350-1355

[2] Wolchok JD(2017)iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics Lancet Oncol England 18 e143-e152

[3] Seymour L(2018)Absolute number of new lesions on18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab Eur J Nucl Med Mol Imaging. 45 376-83

[4] Bogaerts J(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 332-336

[5] Perrone A(2011)QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 155 529-61

[6] Ford R(2021)Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments Res Synth Method. 121 55-286

[7] Schwartz LH(2013)Assessing Bias in Studies of Prognostic Factors Annals of Internal Medicine 158 280-16

[8] Mandrekar S(2007)Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 1-22

[9] Anwar H(2020)Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: an observational study PLoS Med 17 1-341

[10] Sachpekidis C(2020)Review manager (RevMan) [computer program] Version 5 4-1782